Litcius/Paper detail

Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression

Darshan S. Chandrashekar, Balabhadrapatruni V. S. K. Chakravarthi, Alyncia D. Robinson, Joshua C. Anderson, Sumit Agarwal, Sai Akshaya Hodigere Balasubramanya, Marie‐Lisa Eich, Akhilesh Kumar Bajpai, Sravanthi Davuluri, Maya S. Guru, Arjun S. Guru, Gurudatta Naik, Deborah L. Della Manna, Kshitish K. Acharya, Shannon Carskadon, Upender Manne, David K. Crossman, James E. Ferguson, William E. Grizzle, Nallasivam Palanisamy, Christopher D. Willey, Michael R. Crowley, George J. Netto, Eddy S. Yang, Sooryanarayana Varambally, Guru Sonpavde

2020Oncogene29 citationsDOI

Topics & Concepts

KinomeBladder cancerBiologyCancer researchKinaseTyrosine kinaseDasatinibTyrosine-kinase inhibitorCancerSignal transductionCell biologyMyeloid leukemiaGeneticsImatinibBladder and Urothelial Cancer TreatmentsFerroptosis and cancer prognosisRenal cell carcinoma treatment